4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001872873-26-000003
PRESIDENT AND CEO gave up 20,988 shares (to pay taxes)
- PRESIDENT AND CEO acquired 83,844 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Option exercise | +15,708 | 5,375,535 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Shares withheld for taxes | −3,825 | $4.23 | $16,180 | 5,371,710 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Option exercise | +29,467 | 5,401,177 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Shares withheld for taxes | −7,747 | $4.23 | $32,770 | 5,393,430 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Option exercise | +38,669 | 5,432,099 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Shares withheld for taxes | −9,416 | $4.23 | $39,830 | 5,422,683 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Grant or award · Employee Stock Option (right to buy) | +485,545 | 485,545 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Grant or award · Restricted Stock Units | +915,407 | 915,407 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Option exercise · Restricted Stock Units | −15,708 | 47,129 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Option exercise · Restricted Stock Units | −29,467 | 176,806 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2026-03-10 | Option exercise · Restricted Stock Units | −38,669 | 348,030 | D | ||
Loading xslF345X05/form4-03122026_080314.xml…